The tumor suppressor p53 plays a crucial role in maintaining the genetic integrity of the cell and in suppressing cell transformation. Its cellular levels are usually low and rise substantially in response to DNA damage. Although research on p53 induction following DNA damage has mainly focused on the post-translational modification of p53 by Mdm2, it is known that protein translation also contributes to p53 induction. However, the mechanisms underlying translational regulation of the p53 protein in response to DNA damage are still poorly understood. We show that p53 synthesis increases dramatically in MCF-7 cells treated with etoposide. Interestingly, this increase is accompanied by an increase in the association of the translation initiation factor eIF-4E with its binding protein 4E-BP1, an inhibitor of cap-dependent protein translation. We further identified an internal ribosomal entry site (IRES) located in the 5 0 -untranslated region of the p53 transcript, that is capable of driving the cap-independent translation of a downstream cistron encoding Firefly luciferase in a dicistronic expression vector. Moreover, we found that the activity of the IRES element increases in response to etoposide-induced DNA damage in MCF-7 cells. These findings provide a novel mechanism for the regulation of p53 translation in response to DNA damage.
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The tumor suppressor protein p53 inhibits cell transformation by stopping cell growth or triggering apoptosis. It is mutated in more than half of all human cancers, and the inactivation of the p53 pathway plays a major role in the process of oncogenesis (Vogelstein et al., 2000) . In unstressed cells, p53 levels are low and it is in an inactive form. However, after a stressful event such as DNA damage, p53 becomes activated and its levels increase substantially (Giaccia and Kastan, 1998) .
Although it is known that p53 is stabilized and therefore accumulates in the cell after DNA damage, there is also clear evidence showing that an increase in p53 synthesis in response to DNA damage, such as ionizing radiation (IR) or ultraviolet (UV) irradiation, also contributes to increased p53 levels in the cell (Giaccia and Kastan, 1998) . It was shown that cycloheximide (CHX), a protein elongation inhibitor, blocked the increase in p53 levels in ML-1 cells after exposure to IR (Kastan et al., 1991) . Subsequently, it was demonstrated that p53 biosynthesis increases rapidly in response to IR in mouse 3T3 cells, even after treating the cells with the transcription inhibitor actinomycin D (Mosner et al., 1995) . Also, exposure to IR was found to lead to an increase in the association of p53 mRNA with polysomes, which further suggests an increase in p53 translation (Fu and Benchimol, 1997) . Moreover, a recent report showed that p53 biosynthesis increases substantially in response to short wave ultraviolet light (UVC) irradiation (Mazan-Mamczarz et al., 2003) .
It is known that etoposide mimics IR-induced DNA damage by causing DNA double-strand breaks (Quinn et al., 2003) . We first treated MCF-7 cells, a breast carcinoma cell line expressing wild-type p53, with etoposide to examine its effect on p53 induction. We found that p53 accumulated in the cell following etoposide treatment. However, addition of CHX greatly inhibited p53 induction (Figure 1a) , as was observed in ML-1 cells (Kastan et al., 1991) . Further experiments indicated that the increase in p53 levels in response to etoposide cannot be accounted for by increased half-life or protein stabilization alone, since the levels of p53 accumulated after etoposide treatment were higher than those found in MCF-7 cells treated with N-acetyl-Lleucinyl-L-leucinyl-L-norleucinal (ALLN), a proteasome inhibitor (Figure 1b) . These results suggest that newly synthesized p53 contributes to elevated p53 levels in response to etoposide-induced DNA damage. To further determine whether p53 translation increases following etoposide treatment, we measured levels of de novo p53 protein synthesis after labeling MCF-7 cells with 35 SMethionine for 20 min. A substantial increase in the levels of newly synthesized p53 was observed in etoposide-treated cells as compared to the control cells ( Figure 1c) . As the cells were only labeled for a brief amount of time, this should reflect an increase in p53 translation and not an increase in its half-life. To further confirm that p53 is translationally regulated in response to DNA damage, we examined whether the p53 mRNA is associated with large polysomes following etoposide treatment. Two populations of ribosomal extracts containing polyribosomal mRNA or postpolyribosomal (monosomal) mRNA were prepared from a cytoplasmic extract of the MCF-7 cells treated with or without etoposide (Figure 1d ). RNA was purified from these fractions. The purified polyribosomal RNA, postpolyribosomal (monosomal) RNA, and the total RNA in the cytosol were all subjected to reverse transcription-polymerase chain reaction (RT-PCR). Analysis of the PCR products (Figure 1e ) showed that the total p53 mRNA level in the cytosol did not change when the cells were treated with etoposide. However, the levels of p53 mRNA in polyribosomal and postpolyribosomal (monosomal) mRNA fractions before and after etoposide treatment did change. In response to etoposide, the p53 mRNA redistributed from the monosomal fraction to the polyribosomal fraction of the cytoplasm. These results further demonstrate that the accumulation of p53 protein following etoposide treatment was accompanied by an increase in the translation of p53 mRNA.
Most of the eukaryotic mRNAs have a 7-methylguanosine cap at their 5 0 -end. The translation initiation factor eIF-4E is capable of recognizing the 5 0 -cap. This event is typically the rate-limiting step in cap-dependent protein translation initiation (Gingras et al., 1999) . The eIF-4E binding protein 1 (4E-BP1, also called PHAS-I) inhibits cap-dependent protein translation by binding to eIF-4E, since both 4E-BP1 and eIF-4G bind to and compete for the same site on eIF-4E (Lawrence and Abraham, 1997) . eIF-4G is a scaffolding protein necessary for the formation of the eIF-4F translation initiation complex. The phosphorylation status of 4E-BP1 affects its ability to bind eIF-4E. In quiescent or stressed cells, 4E-BP1 is hypophosphorylated and binds tightly to eIF-4E. Kastan, 2000) and causes the release of eIF-4E from 4E-BP1, which facilitates the translation of capped mRNA by making eIF-4E available for binding to eIF-4G. In situations of cellular stress when cap-dependent translation is inhibited by 4E-BP1, cap-independent protein translation, mediated by internal ribosome entry sites (IRES) at the 5 0 -untranslated region (UTR) of mRNAs, is required to maintain the expression of needed proteins (Hellen and Sarnow, 2001) . Internal ribosome entry sites are structured elements that are capable of recruiting the 40S ribosomal subunit, aided by a subset of protein translation factors without the need for eIF-4E and its cap-binding ability. Internal ribosome entry sites were first noted in picornaviruses (Hellen and Sarnow, 2001 ) and were subsequently identified in a number of cellular mRNAs (Holcik, 2004; Spriggs et al., 2005) . Cellular IRESs appear to be important for the regulation of the expression of certain critical proteins involved in cell growth, survival or death during cellular stress (Komar and Hatzoglou, 2005) . These proteins include the oncogene c-Myc (Stoneley et al., 1998) , the antiapoptotic factors XIAP and BCL-2 (Holcik et al., 1999; Sherrill et al., 2004) , and the cell growth inhibitor p27 (Miskimins et al., 2001) .
Next, we investigated whether the increased p53 synthesis in response to etoposide is due to enhanced cap-dependent protein translation. It was previously demonstrated that exposure to IR impairs cap-dependent protein translation by causing increased association between eIF-4E and 4E-BP1, which also leads to a decrease in overall protein synthesis (Kumar et al., 2000) . It is known that rapamycin inhibits 4E-BP1 phosphorylation and causes increased association between 4E-BP1 and eIF-4E. Thus, rapamycin has been used as a specific inhibitor of cap-dependent protein translation (Pyronnet et al., 2000) . In contrast to CHX, rapamycin treatment did not inhibit the induction of the p53 protein in etoposide-treated MCF-7 cells (Figure 2a ). Moreover, we isolated eIF-4E and its binding proteins from MCF-7 cells treated with etoposide and observed a time-dependent increase in the association between 4E-BP1 and eIF-4E in those cells ( Figure 2b ). We also found that general protein synthesis was inhibited by etoposide treatment (data not shown). The above results indicate that the increase in p53 translation after etoposide treatment does not occur in a cap-dependent manner.
In order to assess if the 5 0 -UTR of the p53 mRNA has IRES activity, a dicistronic reporter construct named pRF (Stoneley et al., 1998) was used. It contains both a Renilla luciferase (Rluc) and a Firefly luciferase (Fluc) coding region separated by a short spacer region (Figure 2c ). The Rluc coding region is translated in a cap-dependent manner, whereas the Fluc coding region can only be translated in a cap-independent fashion if an IRES-containing sequence is placed upstream of it.
It was previously reported that the major transcription start site for the p53 gene is around À140 bp of its open reading frame (ORF) (Tuck and Crawford, 1989) . A cDNA fragment containing the majority of the 5 0 -UTR region (À131 to À1 bp from the ORF) of the p53 mRNA was subcloned before the Fluc coding Fractions containing polyribosome or postpolyribosome (monosome) were separated using a method modified from a previous paper (Mukhopadhyay et al., 2003) . Briefly, following treatment with etoposide, cells were lysed in 200 ml of polysomal buffer (10 mM MOPS, pH 7.2, 250 mM NaCl, 2.5 mM MgOAc, 0.5% NP-40, 1 mM PMSF, 200 mg/ml heparin and 50 mg/ml CHX) for 10 min. Cellular debris and nuclei were removed from the cell lysates by centrifugation at 12 000 Â g for 10 min. A portion of the supernatant was saved for isolation of total cytoplasmic RNA (T). Polysomes in the supernatant were precipitated by ultracentrifugation at 100 000 g for 1 h in a 75 Ti rotor (Beckman) at 41C, and the supernatant after ultracentrifugation was used as the source of postpolysomal (monosomal) fraction. The pellet from the above step was resuspended in 200 ml of polysomal buffer, and the resuspended solution was used as polysomal fraction. The RNAs from polysomal and postpolysomal fractions, as well as the total cytoplasmic extracts were isolated using TRI-reagent LS (Molecular Research Center Inc.). The recovered RNAs were further purified by an RNeasy Mini kit (Qiagen, Valencia, CA, USA), treated by RNase-free DNase (Qiagen), and were subjected to reverse transcription-polymerase chain reaction (RT-PCR) analysis for the p53 mRNA. (e) Polymerase chain reaction products obtained from the RT-PCR reactions. Briefly, total cytoplasmic RNA, polysomal RNA, and postpolysomal (monosomal) RNA were all subjected to reverse transcription using Superscriptt First-strand Synthesis System (Invitrogen, Carlsbad, CA, USA). The obtained cDNA was used as a template for PCR using the Expanded High Fidelity PCR System (Roche, Indianapolis, IN, USA). The midpoint for linearity of the exponential phase of amplification of the p53 mRNA was determined to be 25 cycles (denaturation at 951C for 60 s, annealing at 551C for 30 s, and elongation at 721C for 60 s). The PCR products were resolved in a 1.0% agarose gel stained with ethidium bromide. The results shown are representatives of three separate experiments.
p53 protein synthesis and DNA damage D-Q Yang et al region in the pRF vector. This new construct (pR5UTRF) was used to assess the putative capindependent protein translation of Fluc under the control of the p53 5 0 -UTR, using the Rluc activity as an internal control. The pREMCVF construct, which contains a sequence corresponding to the encephalomyocarditis virus (EMCV) IRES before the Fluc coding region of the pRF vector (Stoneley et al., 1998) , was used as a positive control. 293T-17 cells were transfected with the above reporters, and the dual-luciferase assays were performed. The results show that the Fluc/Rluc ratio of the pR5UTRF vector was 200-fold higher than that of the pRF vector, and about 30-fold higher than that of the pREMCVF vector. These results suggest that a putative IRES element is present in the 5 0 -UTR of the p53 mRNA (Figure 2d) .
To find out which segment of the 5 0 -UTR is necessary for its IRES activity, we deleted a sequence corresponding -GTP Sepharose beads using a procedure modified from a previous report (Yang and Kastan, 2000) . Isolated samples were then subjected to SDS-PAGE. Both eIF-4E and 4E-BP1 were visualized by immunoblotting using antibodies (Yang and Kastan, 2000) against eIF-4E and 4E-BP1, respectively. (c) Map of the pRF dicistronic report. The pRF vector contains an SV40 promoter that drives the transcription of Rluc gene and Fluc gene. The pREMCVF construct contains a sequence of encephalomyocarditis virus (EMCV) internal ribosomal entry sites (IRES) inserted between SpeI and NcoI sites of the pRF vector. The 5 0 -UTR (À131 to À1) sequence of the p53 mRNA was amplified from the pRST/hUTR-luc-plus vector and was inserted between SpeI and NcoI sites of pRF to form the pR5UTRF vector. The pRDNF vector was generated by deleting the first 70 nucleotides from the 5 0 -UTR of the p53 transcript in the PR5UTRF vector. (d) Ratios of Fluc/Rluc after transient transfection of the luciferase reporters into 293T-17 cells. Subconfluent 293T-17 cells were transfected with pRF, pREMCVF, pR5UTRF or pRDNF, respectively, using the Lipofectamine reagent (Invitrogen). At 24 h after transfection, cells were lysed using a Passive Lysis buffer (Promega, Madison, WI, USA). Cell lysates were then centrifuged, and the supernatant was saved for analysis. Luciferase assays were performed using a dual-luciferase assay kit according to the manufacturer's instructions (Promega). Fluc and Rluc activities were determined using a Sirius Dual-injector Luminometer (Berthold Detection Systems, Oak Ridge, TN, USA). The data shown are averages7s.e. of Fluc/Rluc ratio from three individual experiments.
p53 protein synthesis and DNA damage D-Q Yang et al to the first 70 nucleotides of the 5 0 -UTR from the pR5UTRF vector and generated a new construct called pRDNF. This deletion led to a dramatic 98% decrease in the Fluc/Rluc ratio as compared to the ratio obtained with the pR5UTRF vector. This result indicates that the first 70 nucleotides of the p53 5 0 -UTR are responsible for the vast majority of the putative IRES activity of the p53 mRNA (Figure 2d) .
However, the presence of cryptic splice sites or a promoter sequence in the intercistronic sequence (the p53 5 0 -UTR before the Fluc coding region) can also lead to the formation of a functional Fluc transcript, which may increase its expression and lead to false positive results (Hellen and Sarnow, 2001 ). The pR5UTRF vector or the pRF vector was transiently transfected into 293T-17 cells, and total RNA was extracted in order to examine if the pR5UTRF construct contains cryptic splice sites. The region stretching from the end of the SV40 promoter sequence (downstream of the transcription start site) to the start of the Fluc coding region was amplified by RT-PCR. Only cDNAs of the expected length were observed (Figure 3a) . No bands were seen in RNA samples amplified by PCR alone (data not shown). The results indicate that there are no cryptic splice sites in the 5 0 -UTR of the p53 mRNA. To test if the 5 0 -UTR of the p53 transcript has promoter activity, the 131 bp cDNA fragment corresponding to the 5 0 -UTR region was subcloned into a pGL3/basic vector to yield a pGL3/5UTR construct. The pGL3/basic vector contains a Fluc coding region that has no upstream promoter or downstream enhancer. The pGL3/control vector contains an upstream SV40 promoter as well as a downstream SV40 enhancer for the Fluc coding region, and was used as a positive control. We found that the Fluc activity in cells transfected with pGL3/5UTR was slightly lower than that in cells transfected with the pGL3/basic vector. The luciferase activity from cells transfected with the pGL3/control vector is much higher than that from cells transfected with the pGL3/basic or the pGL3/5UTR vector (Figure 3b) . Moreover, the fragment containing the p53 5 0 -UTR was also subcloned into a pGL3/enhancer vector to yield a pGL3E/5UTR construct. The pGL3/enhancer vector contains a Fluc coding region that is followed by a downstream SV40 enhancer. We again found that the Fluc activity in cells transfected with pGL3E/5UTR was slightly lower than that in cells transfected with the pGL3/enhancer vector. The luciferase activity from cells transfected with the pGL3/control vector is much higher than that from cells transfected with the pGL3/enhancer or the pGL3E/ 5UTR vector (Figure 3c ). These results demonstrate that the 5 0 -UTR of the p53 transcript does not have promoter activity.
To test whether the IRES element of the p53 mRNA is active in cell lines other than 293T-17, MCF-7 cells A plasmid encoding either pRF or pR5UTRF was transfected into 293T-17 cells using Lipofectamine. Total cellular RNA was extracted using the RNeasy Mini Kit (Qiagen) and was treated with an RNase-free DNase kit (Qiagen). The RNA was then subjected to RT using Superscriptt First-strand Synthesis System (Invitrogen) followed by a PCR reaction (30 cycles) using the Expanded High Fidelity PCR System (Roche). The PCR products were resolved in a 1.0% agarose gel stained with ethidium bromide. The result shown is representative of three individual experiments. (b) Luciferase assays of 293T-17 cells transiently transfected with the pGL3/basic, pGL3/5UTR, or pGL3/control vectors. Both the pGL3/basic and pGL3/control vectors were from Promega. The pGL3/5UTR vector was constructed by inserting the 5 0 -UTR sequence (À131 to À1) of the p53 mRNA between the HindIII and NcoI sites of the pGL3-basic vector. At 24 h after transfecting these vectors into 293T-17 cells, cells were lysed, and Fluc assays were performed using a Fluc assay kit (Promega) as described in Figure 2 . (c) Luciferase assays of 293T-17 cells transiently transfected with the pGL3/enhancer, pGL3E/5UTR, or pGL3/control vectors. The pGL3/enhancer vector was also from Promega. The pGL3E/5UTR vector was constructed by inserting the 5 0 -UTR sequence (À131 to À1) of the p53 mRNA between the HindIII and NcoI sites of the pGL3/enhancer vector. DNA transfection and Fluc assays were performed as described above. The data shown in both (b) and (c) are averages7s.e. of Fluc/mg protein from three individual experiments. (Figure 4a ). Although the results are not as dramatic as those seen in 293T-17 cells, the IRES activity of the p53 mRNA could also be observed in MCF-7 cells. The difference in the levels of IRES activity observed in the two cell lines is probably due to the intrinsic differences between the two cell types (Hellen and Sarnow, 2001) . Furthermore, the first 70 nucleotides of the p53 5 0 -UTR were also shown to be responsible for the majority of the p53 IRES activity observed in MCF-7 cells, since the Fluc/Rluc ratio of the pRDNF vector was similar to that of the pRF vector (Figure 4a) .
Previous studies have shown that the activity of certain IRESs, such as those found in the antiapoptotic factors XIAP and BCL-2, increases in response to IR or etoposide treatment (Holcik et al., 1999; Sherrill et al., 2004) . It was also reported that the IRES element of c-Myc also mediates increased c-Myc protein synthesis following mitomycin C-induced DNA damage (Sullivan and Willis, 1989) . In order to test if etoposide treatment can lead to an increase in the p53 IRES activity, MCF-7 cells transfected with pR5UTRF were treated with etoposide. Dual-luciferase assays showed a nearly 40% increase in p53 IRES activity in cells treated with etoposide in comparison with the untreated cells, whereas cells transfected with pRF had a 30% reduction of Fluc/Rluc ratio after similar treatment (Figure 4b ). These results, along with our other findings, suggest that the IRES structure at the 5 0 -UTR of the p53 mRNA may play a key role in stimulating p53 biosynthesis in response to etoposide-induced DNA damage.
Several proteins that can bind to the 3 0 -UTR of p53 mRNA and modulate its translation were identified (Fu et al., 1999; Mazan-Mamczarz et al., 2003; Schumacher et al., 2005 ). An RNA-binding protein, HuR, has been shown to mediate the UVC-induced increase in p53 translation by binding to the 3 0 -UTR of the p53 transcript following UVC irradiation (Mazan-Mamczarz et al., 2003) . Furthermore, a 40 kDa protein was found to bind the 3 0 -UTR of the p53 transcript. It is thought that the protein binds to the 3 0 -UTR and inhibits p53 translation under normal growth conditions. Following IR, the protein is released from the 3 0 -UTR and facilitates p53 translation (Fu et al., 1999) . It is possible that the increase we observed in the p53 IRES activity after etoposide treatment might not be enough to account for the dramatic increase in p53 biosynthesis seen after exposure to the DNA damaging agent. The 3 0 -UTR of p53 mRNA as well as its binding proteins might be required for the full enhancement of p53 translation.
A number of proteins that bind to the cellular IRES sequences have been identified and named 'IRES transactivating factors' or ITAFs (Hellen and Sarnow, 2001) . Murine p53 was also found to inhibit its own translation by binding to the 5 0 -UTR and a portion of the ORF of its mRNA under normal growth conditions. This inhibition is thought to be released after IR as well (Mosner et al., 1995) . In a recent article by Takagi et al. (2005) , the ribosomal protein L26 (RPL26), a component of the 60S large ribosomal subunit, was found to bind the human p53 5 0 -UTR after DNA damage, thereby enhancing p53 translation. Nucleolin was identified as another protein bound to the p53 5 0 -UTR, and its binding represses p53 translation. In addition, several other proteins, including p53, have also been found to interact with the human p53 5 0 -UTR. However, the mechanism by which RPL26 and nucleolin regulate p53 translation after DNA damage is still unclear. It will be interesting to study if these proteins, as well as p53 itself, act as ITAFs to regulate the IRES activity of the p53 mRNA in response to DNA damage. Characterization of the role of potential ITAFs in the translational regulation of the p53 induction following DNA damage may provide new insights into the mechanisms of inactivation of p53 in the pathogenesis of cancer. 0 -UTR in MCF-7 cells. After transfecting MCF-7 cells with pRF or pR5UTRF vectors, cells were treated with or without 10 mM etoposide for 2 h. They were then lysed, and dual-luciferase assays were performed. The data shown above are averages7s.e. of Fluc/ Rluc ratio from three individual experiments.
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